Diamyd chart has repeated this descending wedge pattern, followed by breakouts, thrice during the past three months. A fourth inning is in sight, as they are getting ready to head into the phase III clinical trials (labeled "DIAGNODE-3") of their diabetes vaccine "Diamyd".
After breaking through the $38,81 support yesterday, AMC started correcting inside the new range of $33,7-$37,4 while staying inside the descending wedge.
For the past 32 days, AMC has been trading inside the USD 38,81 - 64,95 range. Today, the price broke out of yesterday's wedge and inched closer to the USD 38,81 handle which also got tested last week and more than a month ago before that. AMC being one of the mainstays at Wallstreet bets subreddit and one of the most talked about stocks of the past months, will...
A falling wedge pattern shaping in the BB price action, with increasingly lower price volatility inside the tapering wedge and MACD crossing, BB is setting up for a breakout upwards. With cyber security being talked about left and right, a reversal could be in the cards.
NASDAQ:MRNA showing telltale signs of the cup and handle bullish pattern , with decreasing volume in the cup base and forming a clear handle after the all-time high, meanwhile MACD is crossing above the signal line inside "the handle".